FDA approves leukemia treatment developed by Celgene, Agios

(Reuters) - The U.S. Food and Drug Administration (FDA) on Tuesday approved Celgene Corp and Agios Pharmaceuticals Inc's treatment for acute myeloid leukemia (AML) patients with a specific genetic mutation.

Athenahealth to conduct strategic review

(Reuters) - Healthcare software provider athenahealth Inc said on Tuesday it would conduct a strategic review of its operations, more than two months after investor Elliott Management said it planned to push operational and strategic changes at the company.

Pfizer quarterly revenue slips 2 percent

(Reuters) - Pfizer Inc reported a nearly 2 percent drop in quarterly revenue on Tuesday, driven by lower demand for its rheumatoid arthritis treatment Enbrel and pneumonia vaccine Prevnar.